Directors' Dealings

Immupharma PLC
18 December 2007


For Immediate Release                                           18 December 2007


                                 ImmuPharma PLC

                               Directors' Dealing

             Powe Capital increases stake in ImmuPharma to over 5%


ImmuPharma PLC (LSE:IMM), ('ImmuPharma' or the 'Company'), announces today that
Powe Capital, through its funds Modulus Europe and Tensor Europe, has increased
its stake in ImmuPharma from 3.12% to 5.59% through a purchase, on 14 December
2007, of 1,800,000 existing ordinary shares of 10 pence each in the Company from
the Trusts of two of ImmuPharma's founders and Directors, Richard Warr and
Dimitri Dimitriou.


The subsequent interests are as follows:

               Shares     Price per  Subsequent beneficial   Subsequent percent
             purchased      share           holding               interest

Modulus      1,540,000       £0.73              3,808,127                 5.23%
Europe

Tensor         260,000       £0.73                260,000                 0.36%
Europe



               Shares    Price per   Subsequent beneficial   Subsequent percent
               placed      share            holding               interest
Richard Warr  900,000        £0.73             11,878,968                16.32%
(1)

Dimitri
Dimitriou(2)  900,000        £0.73             11,878,969                16.32%



(1) Ordinary shares of £0.10 held by Louvre Trustees where the Warr family has a
beneficial interest.

(2) Ordinary shares of £0.10 held by Louvre Trustees where the Dimitriou family
has a beneficial interest.


Richard Warr, ImmuPharma's Chairman said: 'Powe Capital has been a longstanding
supporter and shareholder of ImmuPharma. We are delighted by the confidence they
have shown in the Company by increasing their stake to over 5%.'



For further information please contact:

ImmuPharma PLC:

Richard Warr, Chairman                                [phone]

Dimitri Dimitriou, Chief Executive Officer            [phone]

Buchanan Communications                               [phone]

Lisa Baderoon

Rebecca Skye Dietrich

Panmure Gordon & Co

Andrew Burnett                                        [phone]



                      This information is provided by RNS
            The company news service from the London Stock Exchange